Page last updated: 2024-10-15

3-hydroxykynurenine and Neurodegenerative Diseases

3-hydroxykynurenine has been researched along with Neurodegenerative Diseases in 4 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research Excerpts

ExcerptRelevanceReference
"Boosting KYNA levels, through interference with the KP enzymes or through application of prodrugs/analogs with high bioavailability and potency, is a promising clinical approach."2.82Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword? ( Ostapiuk, A; Urbanska, EM, 2022)
"3-Hydroxykynurenine has been largely described as one of these toxic metabolites capable of inducing oxidative damage and cell death; consequently, this metabolite has been hypothesized to play a pivotal role in different neurological and psychiatric disorders."2.493-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system. ( Colín-González, AL; Maldonado, PD; Santamaría, A, 2013)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Ostapiuk, A1
Urbanska, EM1
Capucciati, A1
Galliano, M1
Bubacco, L1
Zecca, L1
Casella, L1
Monzani, E1
Nicolis, S1
Vecsei, L1
Plangar, I1
Szalardy, L1
Colín-González, AL1
Maldonado, PD1
Santamaría, A1

Reviews

2 reviews available for 3-hydroxykynurenine and Neurodegenerative Diseases

ArticleYear
Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?
    CNS neuroscience & therapeutics, 2022, Volume: 28, Issue:1

    Topics: Alzheimer Disease; Animals; Brain; Excitatory Amino Acid Antagonists; Humans; Huntington Disease; Ky

2022
3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system.
    Neurotoxicology, 2013, Volume: 34

    Topics: Animals; Antioxidants; Biotransformation; Central Nervous System; Humans; Kynurenine; Neurodegenerat

2013

Other Studies

2 other studies available for 3-hydroxykynurenine and Neurodegenerative Diseases

ArticleYear
Neuronal Proteins as Targets of 3-Hydroxykynurenine: Implications in Neurodegenerative Diseases.
    ACS chemical neuroscience, 2019, 08-21, Volume: 10, Issue:8

    Topics: alpha-Synuclein; Amyloid beta-Peptides; Cells, Cultured; Chromatography, Liquid; Humans; Kynurenine;

2019
Manipulation with kynurenines: a possible tool for treating neurodegenerative diseases?
    Expert review of clinical pharmacology, 2012, Volume: 5, Issue:4

    Topics: Animals; Drug Design; Humans; Kynurenic Acid; Kynurenine; Neurodegenerative Diseases; Quinolinic Aci

2012